Dr APJ.Abdul Kalam lauds Sankara Nethralaya’s pioneering role in Stem Cell research, in his inaugural address at the Asia-ARVO

Sankara Nethralaya Medical Research Foundation has organized South East Asia Glaucoma Interest Group Conference where the thought of retinal neuronal dysfunction through glaucoma was discussed. They also provided a future direction for glaucoma therapy by prevention or delay or reverse decay of the retinal ganglion cells and axons. The organizers found that results of genomics and proteomics will play a vital role in early detection of glaucoma. Stem cells may help restore vision in patients who have glaucoma, by repopulating or rescuing damaged cells. Stem cells can also be used for terminal stages of glaucoma. A few of our ophthalmologists are already working in stem cell therapy. Gene therapy approach is applicable to either lower the intra ocular pressure or protecting retinal ganglion cells. This approach could reprogram the target cells by transferring genetic material into them, so that they lower intra ocular pressure physiologically.

Tags: , , , , , ,
Previous Post

Faculty member of Elite School of Optometry becomes first Indian member of prestigious optometry club

Next Post

Avowed to allay blindness

Comments

    • Kopa Michael
    • May 30, 2014

    Please tell me that youre going to keep this up! Its so great and so important. I cant wait to read more from you. I just feel like you know so a lot and know how to make people listen to what youve to say. This weblog is just too cool to be missed. Wonderful things, definitely. Please, PLEASE keep it up!

Leave a Reply

Your email address will not be published. Required fields are marked *